Aventis Overview

  • Year Founded
  • 1979

Year Founded

  • Status
  • Acquired/​Merged

  • Employees
  • 75,567

Employees

  • Latest Deal Type
  • M&A

  • Financing Rounds
  • 2

  • Investments
  • 11

Aventis General Information

Description

Developer of pharmaceuticals and vaccines for preventative medicine.

Contact Information

Website
www.aventis.com
Formerly Known As
Rhone Poulenc S A
Ownership Status
Acquired/Merged
Financing Status
Formerly PE-Backed
Corporate Office
  • 16 avenue de l'Europe
  • 67300 Schiltigheim
  • France
+33 01
Primary Industry
Pharmaceuticals
Acquirer
Sanofi-Synthelabo
Corporate Office
  • 16 avenue de l'Europe
  • 67300 Schiltigheim
  • France
+33 01

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Aventis Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore Aventis‘s full profile, request access.

Request a free trial

Aventis Patents

Aventis Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
WO-2026050706-A1 Nk cells having reduced cd38 expression and method for producing Pending 30-Aug-2024
US-20250034129-A1 Crystalline forms of (6s,7s)-6-fluoro-7-(2-fluoro-5-methylphenyl)-3-(tetrahydro-2h-pyran-4-yl)-5,6,7,8-tetrahydropyrido[2,3-d]pyrimidine-2,4(1h,3h)-dione Pending 28-Jul-2023
US-20100151463-A1 Method for determining the likelihood of response to her2 inhibitors Inactive 05-Sep-2008
EP-2294215-A1 Tests to predict responsiveness of cancer patients to chemotherapy treatment options Active 12-May-2008
EP-2294215-A4 Tests to predict responsiveness of cancer patients to chemotherapy treatment options Active 12-May-2008 C12Q1/6886
To view Aventis’s complete patent history, request access »

Aventis Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Aventis Former Investors

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info

This information is available in the PitchBook Platform. To explore Aventis‘s full profile, request access.

Request a free trial

Aventis Investments (11)

Aventis’s most recent deal was a Later Stage VC with Scynexis for . The deal was made on 27-Mar-2008.

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
Scynexis 27-Mar-2008 Later Stage VC Drug Discovery
Nereus Pharmaceuticals 06-Mar-2006 Later Stage VC Drug Discovery
Scynexis 13-Feb-2006 Later Stage VC Drug Discovery
Amphora Discovery 08-Dec-2004 Later Stage VC Drug Discovery
Targacept 06-Dec-2004 Later Stage VC Biotechnology
You’re viewing 5 of 11 investments. Get the full list »

Aventis Exits (11)

Aventis’s most recent exit was on 27-Mar-2008 from Scynexis. The exit was categorized as with 7 buyers.

Company Name Exit Date Exit Type Exit Size Status Buyers
Scynexis 27-Mar-2008 Completed
  • 7 buyers
Nereus Pharmaceuticals 06-Mar-2006 Completed
  • 14 buyers
Scynexis 13-Feb-2006 Completed
  • 5 buyers
Amphora Discovery 08-Dec-2004 Completed
  • 7 buyers
Targacept 06-Dec-2004 Later Stage VC Completed
  • 16 buyers
You’re viewing 5 of 11 exits. Get the full list »

Aventis FAQs

  • When was Aventis founded?

    Aventis was founded in 1979.

  • Where is Aventis headquartered?

    Aventis is headquartered in Schiltigheim, France.

  • What is the size of Aventis?

    Aventis has 75,567 total employees.

  • What industry is Aventis in?

    Aventis’s primary industry is Pharmaceuticals.

  • Is Aventis a private or public company?

    Aventis is a Private company.

  • What is the current valuation of Aventis?

    The current valuation of Aventis is .

  • What is Aventis’s current revenue?

    The current revenue for Aventis is .

  • Who are Aventis’s investors?

    HCRx and Paul Capital Partners have invested in Aventis.

  • When was Aventis acquired?

    Aventis was acquired on 12-Aug-2004.

  • Who acquired Aventis?

    Aventis was acquired by Sanofi-Synthelabo.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process